Gregory Went Net Worth & Insider Trades

Gregory Went - Chief Executive Officer, Adamas Pharmaceuticals Inc

As of April 10, 2019

What is Gregory Went's Net Worth?

The current estimated net worth of Adamas Pharmaceuticals Inc's Chief Executive Officer, Gregory Went, is estimated to be about $2.43M . Gregory Went owns about 375,533 units of Adamas Pharmaceuticals Inc common stock. In the last 5 years at Adamas Pharmaceuticals Inc, Gregory Went has sold an estimated value of $1.02M worth.

What is Gregory Went's Past Insider Trading?

Gregory Went's largest purchase order was 3,850 units , worth over $49.96K on November 8, 2018. Gregory Went's largest sale order was 23,088 units , worth over $415.63K on March 19, 2015. In total, Gregory Went has made about 19 transactions over 5 years of their time at Adamas Pharmaceuticals Inc. Gregory Went usually trades in March, with the busiest year in 2015. The most recent transaction was a sale order of 6,319 units , worth over $50.49K on March 21, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Gregory Went's' Mailing Address?

  • Mailing address is C/o Adamas Pharmaceuticals, Inc. 2200 Powell St, Ste 220 Emeryville CA 94608 CA

Adamas Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Neil F. McFarlane 2020 $604,167 $31,300 $431,300 $199,000 $233,220 $193,954 $1,692,941
Neil F. McFarlane 2019 $182,292 - $125,200 $781,250 $957,325 $34,575 $2,080,642
Vijay Shreedhar, Ph.D. 2020 $418,034 $21,700 $224,600 $55,100 $64,367 $58,498 $842,299
Vijay Shreedhar, Ph.D. 2019 $252,344 - $130,200 $321,063 $397,513 $128,974 $1,230,094
Christopher B. Prentiss 2020 $386,667 $20,000 $184,000 $23,200 - $6,912 $620,779
Christopher B. Prentiss 2019 $358,333 - $184,000 $245,188 $298,980 $7,140 $1,093,641
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1328143/000132814321000033/adms2021proxystatement.htm

What are Adamas Pharmaceuticals Inc's Past Insider Trades?

Adamas Pharmaceuticals Inc's most recent insider trade came on June 23, 2021 by Vijay Shreedhar who sold 6,200 units worth $31.98K . In the last 7 years, insiders at Adamas Pharmaceuticals Inc have sold an estimated value of $27.45M and bought an estimated value of $19.72M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are William Ericson, Director,  Gregory Went, Chief Executive Officer,  and Ivan Lieberburg, Director .

Adamas Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...